{"id":"https://openalex.org/W4295259602","doi":"https://doi.org/10.1136/jnnp-2022-ehdn.70","title":"D14 Plasma levels of 24S-hydroxycholesterol are reduced in Huntington disease subjects: preliminary results of a 2-year longitudinal study","display_name":"D14 Plasma levels of 24S-hydroxycholesterol are reduced in Huntington disease subjects: preliminary results of a 2-year longitudinal study","alternate_titles":[],"publication_year":2022,"publication_date":"2022-09-01","ids":{"openalex":"https://openalex.org/W4295259602","doi":"https://doi.org/10.1136/jnnp-2022-ehdn.70"},"language":"en","primary_location":{"id":"doi:10.1136/jnnp-2022-ehdn.70","doi":"https://doi.org/10.1136/jnnp-2022-ehdn.70","is_oa":false,"landing_page_url":"https://doi.org/10.1136/jnnp-2022-ehdn.70","pdf_url":null,"source":{"id":"https://openalex.org/S134773490","display_name":"Journal of Neurology Neurosurgery & Psychiatry","issn_l":"0022-3050","issn":["0022-3050","1468-330X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"D: Wet biomarkers","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W4295259602"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020107828","display_name":"Mario Fichera","orcid":"https://orcid.org/0000-0002-9609-3787","observed_orcids":["https://orcid.org/0000-0002-9609-3787"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mario Fichera","raw_affiliation_strings":["Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014302098","display_name":"Lorenzo Nanetti","orcid":"https://orcid.org/0000-0002-1952-4539","observed_orcids":["https://orcid.org/0000-0002-1952-4539","https://orcid.org/0000-0001-8893-5932"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Lorenzo Nanetti","raw_affiliation_strings":["Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024709611","display_name":"Monica Favagrossa","orcid":"https://orcid.org/0000-0001-6178-1355","observed_orcids":["https://orcid.org/0000-0001-6178-1355"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Monica Favagrossa","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024252409","display_name":"Anna Castaldo","orcid":"https://orcid.org/0000-0003-3459-3521","observed_orcids":["https://orcid.org/0000-0003-3459-3521"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Castaldo","raw_affiliation_strings":["Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009762837","display_name":"Anna Nigri","orcid":"https://orcid.org/0000-0002-1197-5458","observed_orcids":["https://orcid.org/0000-0002-1197-5458"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Anna Nigri","raw_affiliation_strings":["Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084067197","display_name":"Alessia Mongelli","orcid":"https://orcid.org/0000-0003-4405-0643","observed_orcids":["https://orcid.org/0000-0003-4405-0643"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alessia Mongelli","raw_affiliation_strings":["Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020205391","display_name":"Gloria Marchini","orcid":"https://orcid.org/0000-0002-0775-6789","observed_orcids":["https://orcid.org/0000-0002-0775-6789"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Gloria Marchini","raw_affiliation_strings":["Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081473300","display_name":"Cinzia Gellera","orcid":"https://orcid.org/0000-0002-3582-665X","observed_orcids":["https://orcid.org/0000-0002-3582-665X"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cinzia Gellera","raw_affiliation_strings":["Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034991162","display_name":"Marina Grisoli","orcid":"https://orcid.org/0000-0002-7663-446X","observed_orcids":["https://orcid.org/0000-0002-7663-446X"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marina Grisoli","raw_affiliation_strings":["Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000410225","display_name":"Giulia Birolini","orcid":"https://orcid.org/0000-0001-9357-4940","observed_orcids":["https://orcid.org/0000-0001-9357-4940"]},"institutions":[{"id":"https://openalex.org/I4210160365","display_name":"Istituto Nazionale Genetica Molecolare","ror":"https://ror.org/05rb1q636","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210160365"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giulia Birolini","raw_affiliation_strings":["Istituto Nazionale di Genetica Molecolare \u2018Romeo ed Enrica Invernizzi\u2019, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale di Genetica Molecolare \u2018Romeo ed Enrica Invernizzi\u2019, Milan, Italy","institution_ids":["https://openalex.org/I4210160365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064191727","display_name":"Marta Valenza","orcid":"https://orcid.org/0000-0002-7048-9257","observed_orcids":["https://orcid.org/0000-0002-7048-9257"]},"institutions":[{"id":"https://openalex.org/I4210160365","display_name":"Istituto Nazionale Genetica Molecolare","ror":"https://ror.org/05rb1q636","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210160365"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Marta Valenza","raw_affiliation_strings":["Istituto Nazionale di Genetica Molecolare \u2018Romeo ed Enrica Invernizzi\u2019, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale di Genetica Molecolare \u2018Romeo ed Enrica Invernizzi\u2019, Milan, Italy","institution_ids":["https://openalex.org/I4210160365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013551754","display_name":"Renzo Bagnati","orcid":"https://orcid.org/0000-0002-6535-2686","observed_orcids":["https://orcid.org/0000-0002-6535-2686"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Renzo Bagnati","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089027593","display_name":"Alice Passoni","orcid":"https://orcid.org/0000-0001-6003-5932","observed_orcids":["https://orcid.org/0000-0001-6003-5932"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Alice Passoni","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016280779","display_name":"Laura Colombo","orcid":"https://orcid.org/0000-0002-3243-0270","observed_orcids":["https://orcid.org/0000-0002-3243-0270"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Laura Colombo","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042005526","display_name":"Elena F. Cattaneo","orcid":"https://orcid.org/0000-0002-0755-4917","observed_orcids":["https://orcid.org/0000-0002-0755-4917"]},"institutions":[{"id":"https://openalex.org/I4210160365","display_name":"Istituto Nazionale Genetica Molecolare","ror":"https://ror.org/05rb1q636","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I4210160365"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Elena Cattaneo","raw_affiliation_strings":["Istituto Nazionale di Genetica Molecolare \u2018Romeo ed Enrica Invernizzi\u2019, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto Nazionale di Genetica Molecolare \u2018Romeo ed Enrica Invernizzi\u2019, Milan, Italy","institution_ids":["https://openalex.org/I4210160365"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020722865","display_name":"Mario Salmona","orcid":"https://orcid.org/0000-0002-9098-9873","observed_orcids":["https://orcid.org/0000-0002-9098-9873"]},"institutions":[{"id":"https://openalex.org/I19630809","display_name":"Mario Negri Institute for Pharmacological Research","ror":"https://ror.org/05aspc753","country_code":"IT","type":"nonprofit","lineage":["https://openalex.org/I19630809","https://openalex.org/I4210110338","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Mario Salmona","raw_affiliation_strings":["Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy","institution_ids":["https://openalex.org/I19630809"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5047376869","display_name":"Caterina Mariotti","orcid":"https://orcid.org/0000-0003-2405-3564","observed_orcids":["https://orcid.org/0000-0003-2405-3564"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Caterina Mariotti","raw_affiliation_strings":["Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"A25.1","last_page":"A25"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10949","display_name":"Genetic Neurodegenerative Diseases","score":0.986299991607666,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13481","display_name":"Neurological diseases and metabolism","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/huntington-s-disease","display_name":"Huntington's disease","score":0.9490000009536743},{"id":"https://openalex.org/keywords/24s-hydroxycholesterol","display_name":"24S-hydroxycholesterol","score":0.9990000128746033},{"id":"https://openalex.org/keywords/plasma-biomarkers","display_name":"plasma biomarkers","score":0.7730000019073486},{"id":"https://openalex.org/keywords/brain-cholesterol-metabolism","display_name":"brain cholesterol metabolism","score":0.6759999990463257},{"id":"https://openalex.org/keywords/disease-progression","display_name":"disease progression","score":0.7929999828338623},{"id":"https://openalex.org/keywords/neurofilaments","display_name":"neurofilaments","score":0.7960000038146973},{"id":"https://openalex.org/keywords/longitudinal-biomarker-changes","display_name":"longitudinal biomarker changes","score":0.39899998903274536}],"concepts":[{"id":"https://openalex.org/C2780647506","wikidata":"https://www.wikidata.org/wiki/Q190564","display_name":"Huntington's disease","level":3,"score":0.7250478863716125},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4599643349647522},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.30258065462112427},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2802240252494812}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1136/jnnp-2022-ehdn.70","doi":"https://doi.org/10.1136/jnnp-2022-ehdn.70","is_oa":false,"landing_page_url":"https://doi.org/10.1136/jnnp-2022-ehdn.70","pdf_url":null,"source":{"id":"https://openalex.org/S134773490","display_name":"Journal of Neurology Neurosurgery & Psychiatry","issn_l":"0022-3050","issn":["0022-3050","1468-330X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"D: Wet biomarkers","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2136140769","https://openalex.org/W2052496080","https://openalex.org/W7222927379","https://openalex.org/W2350796710","https://openalex.org/W2021095792","https://openalex.org/W7150749034","https://openalex.org/W4415007644","https://openalex.org/W2055998713","https://openalex.org/W2945629245","https://openalex.org/W7222955724"],"abstract_inverted_index":{"Objectives":[0],"Brain":[1,24],"cholesterol":[2,244],"is":[3,10],"produced":[4],"in":[5,31,45,79,137,141,146,158,164,199,202,206,210,214,219,229,240,249],"situ":[6],"and":[7,38,55,67,71,83,88,98,105,144,161,217,233],"its":[8,89],"turn-over":[9],"ensured":[11],"by":[12],"the":[13,21,57,125,186],"conversion":[14],"into":[15],"24S-hydroxycholesterol":[16],"(24-OHC)":[17],"which":[18],"can":[19],"cross":[20],"blood-brain":[22],"barrier.":[23],"biosynthesis":[25],"was":[26],"shown":[27],"to":[28,50,185],"be":[29],"reduced":[30,44,157],"murine":[32],"models":[33],"of":[34,151,176,178],"Huntington\u2019s":[35],"disease":[36,61,182,189,231],"(HD)":[37],"24-OHC":[39,52,155,179,191,224],"plasma":[40,58,116,225],"concentrations":[41,226],"were":[42,91,122,136,193],"found":[43],"HD":[46,81,120],"patients.":[47],"We":[48,73,171],"aimed":[49],"investigate":[51],"longitudinal":[53],"changes":[54],"correlate":[56],"levels":[59,192],"with":[60,166],"progression,":[62],"basal":[63],"ganglia":[64],"MRI":[65],"volumes,":[66],"neurofilament":[68],"concentrations.":[69],"Participants":[70],"Methods":[72],"conducted":[74],"a":[75,174,236,246],"2-year":[76],"observational":[77],"study":[78],"78":[80],"subjects":[82,109,121,135],"64":[84],"healthy":[85],"controls.":[86],"Cholesterol":[87],"metabolites":[90],"measured":[92],"using":[93,124],"two":[94],"different":[95],"in-house":[96],"developed":[97],"validated":[99],"methods":[100],"based":[101],"on":[102],"liquid":[103],"chromatography":[104],"mass":[106],"spectrometry.":[107],"Fifty-eight":[108],"underwent":[110],"3T-MRI":[111],"for":[112],"brain":[113],"morphometry.":[114],"Neurofilament":[115],"measures":[117],"are":[118],"ongoing.":[119],"classified":[123],"novel":[126],"Huntington":[127],"Disease":[128],"Integrated":[129],"Staging":[130],"System":[131],"(HD-ISS).":[132],"Results":[133],"Twenty-one":[134],"stage":[138,142,147,159],"0-1;":[139,204],"11":[140],"2;":[143,208],"46":[145],"3(a-c).":[148],"Preliminary":[149],"analyses":[150],"baseline":[152],"data":[153],"showed":[154],"significantly":[156],"3b":[160],"3c":[162],"patients":[163],"comparison":[165],"controls":[167],"(p=0.03;":[168],"p<0.02":[169],"respectively).":[170],"also":[172],"observed":[173],"trend":[175],"reduction":[177],"from":[180],"prodromal":[181],"stages":[183],"(0-1)":[184],"late":[187],"manifest":[188],"stages.":[190],"40.+/-1.9":[194],"ng/ml":[195],"(mean":[196],"+/-":[197],"SEM)":[198],"controls;":[200],"33.6+/-3.8":[201],"HD-stage":[203,207,211,215,220],"34.3+/-5.5":[205],"30.9+/-3.9":[209],"3a;":[212],"29.3+/-2.5":[213],"3b;":[216],"23.3+/-1.9":[218],"3c.":[221],"Conclusions":[222],"Monitoring":[223],"may":[227,234],"contribute":[228],"following":[230],"progression":[232],"represent":[235],"valuable":[237],"outcome":[238],"measure":[239],"clinical":[241],"trials":[242],"testing":[243],"as":[245],"candidate":[247],"drug":[248],"HD.":[250]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4295259602","counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2022-09-12T00:00:00"}
